Tag: CDMO

A contract manufacturing organization (CMO) or contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
Services offered by CMOs include, but are not limited to: pre-formulation, formulation development, stability studies, method development, pre-clinical and Phase I clinical trial materials, late-stage clinical trial materials, formal stability, scale-up, registration batches and commercial production. CMOs are contract manufacturers, but they can also be more than that because of the development aspect.

FAREVA will use TraceLink serialization solutions for FMD compliance

marking
TraceLink announced that FAREVA has selected TraceLink's serialization solutions to ensure compliance with the EU Falsified Medicines Directive (FMD).

Ajinomoto Althea and OmniChem formed Ajinomoto Bio-Pharma Services

research
Ajinomoto Althea and OmniChem are integrating their businesses and operations as a unified CDMO, and changing their name to Ajinomoto Bio-Pharma Services.

Piramal Pharma Solutions launches Xcelerate platform

research tube
Piramal Pharma Solutions (PPS), a global leader in Contract Development and Manufacturing Solutions, announced the launch of its Xcelerate Integrated Solutions™ platform.

Almac Group strengthens its position in the CDMO market

almac
Almac Group, the global contract development and manufacturing organisation, announced its global analytical services capabilities spanning UK, Europe and USA.

Idifarma announced renewal of its EU-GMP certificate

api
Idifarma, a Spanish contract development and manufacturing organisation (CDMO), announced the installation of GEA Niro Mobile Minor equipment in a new dedicated area in its EU GMP plant.

Recipharm receives EMVO approval

recipharm
Recipharm, a leading contract development and manufacturing organisation has received European Medicines Verification Organisation (EMVO) approval to submit serialisation data to the European Hub.

Avara obtains sterile manufacturing facility from Sandoz

pharma-market
Avara Pharmaceutical Services announced that it has closed on the transaction with Sandoz to acquire the largest sterile manufacturing facility for injectable medicines in Canada.

AMRI signed collaboration agreement with Metrion Biosciences

lab
AMRI and Metrion Biosciences Limited, the specialist ion channel CRO and drug discovery company, announced they have signed a new collaboration agreement.

AGC will boost its GMP-compliant pharma production

chemistry
AGC announced a major expansion of facilities at its Chiba Plant that will result in an increase in the company’s GMP-compliant synthetic pharmaceutical intermediate and active ingredient production capacity.

Novacap acquires PCI Synthesis CDMO

research
Novacap announced that it has signed an agreement to acquire Boston-based PCI Synthesis, a leading U.S. pharmaceutical contract development and manufacturing organization (CDMO).

Stelis Biopharma and Oncobiologics start a new CDMO

biotechnologies
Marketed under the name, Bio2Source, Oncobiologics and Stelis Biopharma will offer development stage biotech companies access to a suite of CDMO services.

Global CDMO Recipharm makes its preparations for Brexit

investment
Recipharm, the contract development and manufacturing organisation (CDMO), has established a dedicated taskforce to manage the potential impact of Brexit on its organisation.

Avara buys the largest sterile manufacturing facility in Canada

sterile-manufacturing
Avara Pharmaceutical Services, a world-class contract development and manufacturing organization acquires the largest sterile manufacturing facility for injectable medicines in Canada from a leading global pharmaceutical company.

Recipharm and Hadasit started a partnership

laboratory
Recipharm, the contract development and manufacturing organisation (CDMO), has partnered with Hadasit Medical Research Services and Development to offer combined clinical, biological and chemical services.

Ardena boosts its API manufacturing capabilities by acquiring Syntagon

api
Contract development and manufacturing organisation (CDMO) Ardena has acquired Syntagon, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients.

Avid Bioservices will expand and optimize its capabilities

lab
Avid Bioservices, a dedicated contract development and manufacturing organization, published an update on the company's ongoing efforts to expand and optimize its process development capabilities and laboratory space.